NIS - libdoc.who.int - World Health Organization

Herba Pegani harmalae
60. Al-Shamma A, Mitscher LA. Comprehensive survey of indigenous Iraqi
plants for potential economic value. I. Screening results of 327 species for
alkaloids and antimicrobial agents. Journal of Natural Products, 1979,
42:633–642.
61. Benoit PS et al. Biological and phytochemical evaluation of plants. XIV. Antiinflammatory
evaluation of 163 species of plants. Lloydia, 1976, 39:160–171.
62. Al-Zaid MM et al. Evaluation of blood glucose lowering activity of three
plant diet additives. International Journal of Pharmacognosy, 1991, 29:81–
88.
63. Simonsen HT et al. In vitro screening of Indian medicinal plants for antiplasmodial
activity. Journal of Ethnopharmacology, 2001, 74:195–204.
64. Sathiyamoorthy P et al. Screening for cytotoxic and antimalarial activities in
desert plants of the Negev and Bedouin market plant products. Pharmaceutical
Biology, 1999, 37:188–195.
65. Shapira Z et al. Abortifacient potential for the epigeal parts of Peganum
harmala. Journal of Ethnopharmacology, 1989, 27:319–325.
66. Subhan F et al. Aphrodisiac potential of Peganum harmala seeds. Hamdard-Medicus,
1998, 41:69–72.
67. Lamchouri F et al. Experimental toxicity of Peganum harmala seeds. Annales
Pharmaceutiques Francaises, 2002, 60:123–129.
68. Woo WS et al. Biological evaluation of some Saudi Arabian plants. Journal
of Pharmaceutical Society of Korea, 1977, 21:141.
69. El-Bahri L, Chemli R. Peganum harmala L: a poisonous plant of North
Africa. Veterinary and Human Toxicology, 1991, 33:276–277.
70. Hamouda C et al. Plant poisonings from herbal medication admitted to a
Tunisian toxicologic intensive care unit, 1983-1998. Veterinary and Human
Toxicology, 2000, 42:137–141.
311